AFTER 19th_ELSF
​> ATTENDEES​
​> INVESTORS​
​> PRESENTERS​
​> EXHIBITORS​
​> SPONSORS​
​> SUPPORTERS​

Sachs Associates would like to say that we have enjoyed hosting you in-person and virtually, and thank those who participated in our Sachs Spring Life Sciences Week, which incorporated the 1st Annual European Neuroscience Innovation Forum (#Sachs_ENIF) and the 19th Annual European Life Sciences CEO Forum (#Sachs_ELSF). A special thank you goes to the excellent line-up of sponsors, chairs, panellists, an exhibitor, and presenters who made such a broad and interesting programme possible and to those who participated in-person and during the virtual week.
​
The Life Sciences Week has proven highly successful, with over 500 participants from 27 countries registered and nearly 2300 in-person & online meetings completed.

Publicly available recordings of the sessions and presentations from the event will be uploaded to the SachsTV YouTube channel in April.

We are looking forward to welcoming you again to our future events!

Confirmed Sponsors Included: 

Presenting Companies Included:

Exhibitor Included: 

Confirmed Keynote Speakers Included: 

• Helen Chen, Global Sector Co-Head, Healthcare & Life Sciences | Greater China Managing Partner, L.E.K. Consulting
• Prof. Patrick Aebischer, President Emeritus, École polytechnique fédérale de Lausanne (EPFL)

Confirmed Chairs & Speakers Included: 

• Andreas Wallnoefer, Managing Director, ClavystBio
• Andrew Cavey, CEO, ITM Isotope Technologies Munich SE
• Anja König, Global Head, Novartis Venture Fund
• Ann Beliën, Founder & CEO, Rejuvenate Biomed NV
• Apollon Papadimitriou, CEO, IOmx Therapeutics AG
• Ari-Pekka Laitsaari, Senior Advisor, European Investment Bank
• Björn Cochlovius, CEO, eleva GmbH
• Butrint Aliu, Associate, Pureos Bioventures
• Colette Lipp, Senior Director, Global BD Oncology & Immuno-Oncology, Merck KGaA, Darmstadt, Germany
• Daniel Marshall, Senior Director, Search & Evaluation, Oncology R&D, BD, AstraZeneca
• David G. Benathan, VP, Head BD&L Transactions Oncology & RLT, Novartis Pharma AG
• David Venables, CEO, Laverock Therapeutics Ltd.
• Diana Saraceni, Co-Founder & General Partner, Panakès Partners SGR SpA
• Dominik Hartl, Chief Medical Officer, Granite Bio
• Edward van Wezel, Managing Partner, BioGeneration Ventures (BGV)
• Elena Startseva, Global Clinical Development Lead, Boehringer Ingelheim International GmbH
• Eric Halioua, Executive Chairman, Ervimmune
• Erik van den Berg, CEO, Memo Therapeutics AG
• Esteban Pombo-Villar, Board Member, TargImmune Therapeutics AG
• Esther Melo, Director BD&L, F. Hoffmann-La Roche
• Evonne Sepsis, Managing Director, ESC Advisors
• Fabian Buller, CBO, Neurimmune AG
• Fabrizio Calisti, Medical Director, Angelini Ventures S.p.A.
• Gábor Gyülvészi, Principal/Seed-Stage Investor, Novo Holdings A/S
• Gregory Rall, Deputy Head, Innovation & Technology, InvestHK
• Hemant Sabherwal, Head of Corporate Solutions & EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited (HKEX)
• Henning Steinhagen, Venture Partner, Epidarex Capital
• Jan Poth, Managing Director & CEO, SciRhom GmbH
• Jeremy Griggs, Executive Director, Search & Evaluation, GSK
• Josua Jordi, Chief Scientific Officer, Tanai Therapeutics
• Katharina Kreymborg, SVP, Curie.Bio
• Khatereh Ahmadi, Venture Partner, XGEN Venture SGR SPA
• Konstantin Petropoulos, CEO, Secarna Pharmaceuticals GmbH & Co. KG
• Laura Lane, VP Lilly Ventures  - Head of Europe, Eli Lilly and Company
• Leila Jaafar-Thiel, Founder & CEO, Nuclidium
• Lena Afeyan, Head of UK Science Strategy & Innovation, Flagship Pioneering
• Luca Cassetta, Founder & VP Immunology, Macomics Ltd.
• Lucy Singah, CFO, Resolution Therapeutics
• Madiha Derouazi, CEO, Switchkine SA
• Markus Kalousek, Venture Partner, BioGeneration Ventures (BGV)
• Markus Werner, Head Search & Evaluation Oncology, Novartis Pharma AG
• Melanie de Almeida, Senior Associate, Forbion
• Michael Altorfer, CEO, Swiss Biotech Association
• Michael Bauer, Partner, Novo Holdings A/S
• Michael Wacker, Managing Partner, BioMedVC AG
• Michio Painter, Head, UMZH Translational Medicine Accelerator
• Nigel Sheail, Partner, Versant Ventures
• Odile Rundquist, Partner, Bioqube Ventures
• Olivier Soula, Co-Founder & CEO, ADOCIA
• Paul Hermant, Partner, Bird & Bird (Belgium) LLP
• ​Quin Wills, Founder & CEO, Ochre Bio Ltd.
• Rainer Strohmenger, Managing Partner, Wellington Partners
• Regina Hodits, Managing Director, Angelini Ventures S.p.A.
• Richard Ward, Executive Director, Oncology Search & Evaluation, GSK
• Robert Augustin, Director Strategic Partnering Cardiorenalmetabolism, Global BD&L, Boehringer Ingelheim International GmbH
• Romana Gugenberger, Chief Medical & Scientific Officer, invIOs GmbH ​
• Sarah Holland, CBO, CDR-Life AG
• Steffen-Sebastian Bolz, Chief Scientific Officer, Aphaia Pharma AG
• Stella Gu, Managing Director, Tigermed
• Stephan Lensky, COO & CBO, EpimAb Biotherapeutics
• Stephanie Léouzon, Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
• Tamas Schweighoffer, Co-Founding Partner, Forty51 Ventures AG
• Ted Fjällman, CEO, Flerie Invest AB
• Thierry Laugel, Managing Partner, Kurma Partners
• Victoria English, Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
• Victoria Taylor, Principal, Medicxi
• Ximing Ding, Principal, Pureos Bioventures

To learn more about presenting, exhibition or sponsorship opportunities, please fill in the registration form or contact us at [email protected] or by phone + 44 (0)203 463 4890. 

Bronze Sponsor:

Contributing Sponsors:

---

Supporters:

---

Participating Pharmas Include:

---

Financial, Advisory & Investors Attending:

+ND Capital
3B Future Health Ventures
9vc
ABG Sundal Collier
Afendis Capital Management
AFK & Partners Asset Management LLC
Ampleia
Angelini Ventures S.p.A.
ARCHIMED
Asahi Kasei Ventures
Ascension Ventures
ATHOS KG
AurorA Science Srl
Bergmann zur Hausen & Cie. GmbH
BioGeneration Ventures (BGV)
BiomedVC AG
Bioqube Ventures
BIOSTART Consulting GmbH
Biovision Ventures
BlackRock
Bootstrap Europe
Brandon Capital
Breslin AG
Business Angels Switzerland
Capital Grand Est
Claris Ventures SGR SpA
ClavystBio
CMS Medical Venture Investment Ltd.
Coho VC
Corinthian financial management Ltd
Curie.Bio
DeBere Capital Partners
Dementia Discovery Fund, an SV Health Investors, LLC Fund
Digital Networks PLC
DNB Carnegie
Eight Bridges
Elaia Partners
EQT Life Sciences
ESC Advisors
European Investment Bank
Ferghana Partners, Inc.
Flagship Pioneering
Flerie
Forbion
Fortlane Partners Corporate Finance GmbH
Forty51 Ventures
Forty51 Ventures AG
Generation Fund Life Sciences Fund IV
GIBF
Gilde Healthcare Partners BV
Gimv
GOLDTRACK Ventures GmbH
GordonMD Global Investments LP
Hadean Ventures
HBM Partners AG
Hevolution
High-Tech Gründerfonds Management GmbH
Hong Kong Exchanges and Clearing Limited (HKEX)
Innovestor Life Science Ltd.
IPF Partners
ITM Isotope Technologies Munich SE
JFG Life Sciences Stiftung der Universität Basel
KHAN Technology Transfer Fund
Kurma Partners
Landmark BioVentures
M2care Venture Studio
Medicines Discovery Ventures
Medicxi
Mid Atlantic Bio Angels
Mirabaud & Cie SA
Modi VC
NLC Health Ventures
Novartis Venture Fund
Novo Holdings A/S
Novo Holdings US Inc.
NRW.Venture

​​View Full List